Researchers have pioneered a new catalytic transformation that converts epoxides into fluorinated oxetanes, a coveted but difficult-to-make class of drug molecules that escaped synthetic preparation ...
Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...
18h
Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...
Researchers from the National University of Singapore (NUS) have pioneered a new catalytic transformation that converts ...
The FDA determined that Novo Nordisk’s obesity and diabetes drugs are no longer in short supply. Elsewhere, Concentra made a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback